All News
|
News Release
NIH-supported findings could open up a new field of cardiovascular disease research using cancer therapies to combat the buildup of disease-causing plaque Researchers have discovered that the smooth muscle cells that line the arteries of people with atherosclerosis can change into new cell types and develop traits similar to cancer that worsen the...
Showing 10 out of 114 results
Credit:
Lina Greenberg
|
NHLBI in the Press
To formulate evidence-based guidelines and develop personalized therapies for COVID-19, researchers study how the virus infects different organs and systems – including the heart. A new study identifies underlying pathways and cell changes related to cardiovascular complications from COVID-19.
|
Statement
The National Institutes of Health (NIH) has launched the last of three Phase 3 clinical trials to evaluate the safety and effectiveness of blood thinners to prevent life-threatening blood clots in adults diagnosed with COVID-19. The first patient in the trial was enrolled on February 15. Part of the Accelerating COVID-19 Therapeutic Interventions...
|
NHLBI in the Press
Biological markers of neutrophil activation, an innate immune response, helped medical researchers identify patients who later required intensive care for COVID-19.
|
Media Advisory
Study shows the treatment is safe, but provides no significant benefit in this group What: The National Institutes of Health has halted a clinical trial evaluating the safety and effectiveness of COVID-19 convalescent plasma in treating emergency department patients who developed mild to moderate symptoms of COVID-19, the disease caused by the...
|
NHLBI in the Press
The National Institutes of Health has halted a clinical trial evaluating the safety and effectiveness of COVID-19 convalescent plasma in treating emergency department patients who developed mild to moderate symptoms of COVID-19, the disease caused by the coronavirus SARS-CoV-2.
|
Research Feature
In the early months of the pandemic, alarms sounded after doctors noticed that people with heart disease were faring a lot worse than others who had contracted COVID-19. Almost a year later, researchers are still pondering why these patients get sicker and die at higher rates. But they’re now puzzling over an arguably bigger mystery: why some who...
|
NHLBI in the Press
A review using the Cleveland Clinic’s COVID-19 patient registry found patients who smoked the most throughout their life had higher incidents of being hospitalized for or dying from COVID-19.
|
Media Availability
WHAT: This February, during American Heart Month , experts from the National Heart, Lung, and Blood Institute (NHLBI) are available to discuss the latest science on COVID-19 and heart disease, as well as treatment, risk factors, and lifestyle changes to support cardiovascular health. They will also highlight the importance of preventive measures to...
|
Statement
In large clinical trials conducted worldwide, full dose anti-coagulation (blood thinner) treatments given to moderately ill patients hospitalized for COVID-19 reduced the requirement of vital organ support—such as the need for mechanical ventilation. A trend in possible reduction of mortality was also observed and is being further studied. With...
|
NHLBI in the Press
Using lung cell samples provided by patients, researchers from Northwestern University School of Medicine pinpoint the origins and immune pathways that likely sustain COVID-19 pneumonia.